Exact Mass: 317.2189

Exact Mass Matches: 317.2189

Found 65 metabolites which its exact mass value is equals to given mass value 317.2189, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Butenafine

N-4-Tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride

C23H27N (317.2143)


Butenafine is only found in individuals that have used or taken this drug. It is a synthetic benzylamine antifungal agent.Although the mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells. D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

3-hydroxynonanoyl carnitine

3-[(3-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H31NO5 (317.2202)


3-Hydroxynonanoyl carnitine is an acylcarnitine. More specifically, it is an 3-hydroxynonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxynonanoyl carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxynonanoyl carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-METHYL-3-PYRROLIDIN-1-YLMETHYL-PIPERAZINE-1-CARBOXYLICACIDBENZYLESTER

4-METHYL-3-PYRROLIDIN-1-YLMETHYL-PIPERAZINE-1-CARBOXYLICACIDBENZYLESTER

C18H27N3O2 (317.2103)


   

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)MORPHOLINE

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)MORPHOLINE

C18H28BNO3 (317.2162)


   

1-ETHYL-4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

1-ETHYL-4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

C17H28BN3O2 (317.2274)


   

N-cyclohexyl-2-nitro-4-((piperidin-1-yl)methyl)benzenamine

N-cyclohexyl-2-nitro-4-((piperidin-1-yl)methyl)benzenamine

C18H27N3O2 (317.2103)


   

N,N-diethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

N,N-diethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

C18H28BNO3 (317.2162)


   

N-tert-Butyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

N-tert-Butyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

C18H28BNO3 (317.2162)


   

Dicyclohexyl(4-(N,N-dimethylamino)phenyl)phosphine

Dicyclohexyl(4-(N,N-dimethylamino)phenyl)phosphine

C20H32NP (317.2272)


   

N,N-DIETHYL-2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE

N,N-DIETHYL-2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE

C18H28BNO3 (317.2162)


   

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)PYRROLIDINE

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)PYRROLIDINE

C18H28BNO3 (317.2162)


   

4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine

4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine

C18H28BNO3 (317.2162)


   

ent-7alpha-hydroxykaur-16-en-19-oate

ent-7alpha-hydroxykaur-16-en-19-oate

C20H29O3- (317.2117)


   

18R-hydroxy-eicosapentaenoate

18R-hydroxy-eicosapentaenoate

C20H29O3- (317.2117)


   

epi-leukotriene A4

epi-leukotriene A4

C20H29O3- (317.2117)


   
   

15-oxo-ETE(1-)

15-oxo-ETE(1-)

C20H29O3- (317.2117)


A polyunsaturated oxo fatty acid anion that is the conjugate base of 15-oxo-ETE.

   

(5Z,9E,11Z,14Z)-8-oxoicosa-5,9,11,14-tetraenoate

(5Z,9E,11Z,14Z)-8-oxoicosa-5,9,11,14-tetraenoate

C20H29O3- (317.2117)


   

12-oxo-ETE(1-)

12-oxo-ETE(1-)

C20H29O3- (317.2117)


A oxo fatty acid anion that is the conjugate base of 12-oxo-ETE, obtained by deprotonation of the carboxy group.

   

kauralexin A3

kauralexin A3

C20H29O3- (317.2117)


   

(11S,16S)-ent-kauran-11,16-epoxy-19-oate

(11S,16S)-ent-kauran-11,16-epoxy-19-oate

C20H29O3- (317.2117)


   

(8Z,11Z,14Z,17Z)-3-oxo-icosa-8,11,14,17-tetraenoate

(8Z,11Z,14Z,17Z)-3-oxo-icosa-8,11,14,17-tetraenoate

C20H29O3- (317.2117)


   

leukotriene A4(1-)

leukotriene A4(1-)

C20H29O3- (317.2117)


The leukotriene anion that is the conjugate base of leukotriene A4 arising from deprotonation of the carboxylic acid group. Major microspecies at pH 7.3.

   

5-oxo-ETE(1-)

5-oxo-ETE(1-)

C20H29O3- (317.2117)


A long-chain fatty acid anion that is the conjugate base of 5-oxo-ETE, obtained by deprotonation of the carboxy group.

   

15(R)-Hepe(1-)

15(R)-Hepe(1-)

C20H29O3- (317.2117)


An icosanoid anion that is the conjugate base of 15(R)-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5Z,8Z,11Z,14Z,16E)-18-hydroxyicosa-5,8,11,14,16-pentaenoate

(5Z,8Z,11Z,14Z,16E)-18-hydroxyicosa-5,8,11,14,16-pentaenoate

C20H29O3- (317.2117)


   

20-Oxoarachidonate

20-Oxoarachidonate

C20H29O3- (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 20-oxoarachidonic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

eoxin A4(1-)

eoxin A4(1-)

C20H29O3- (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of eoxin A4, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

17(S),18(R)-EETeTr(1-)

17(S),18(R)-EETeTr(1-)

C20H29O3- (317.2117)


A 17,18-EETeTr(1-) in which the epoxy group has (17S,18R)-configuration.

   

11-oxo-ETE(1-)

11-oxo-ETE(1-)

C20H29O3- (317.2117)


A polyunsaturated oxo fatty acid anion that is the conjugate base of 11-oxo-ETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

17,18-EETeTr(1-)

17,18-EETeTr(1-)

C20H29O3- (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 17,18-EETeTr, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

(6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

(5Z,8Z,11Z,14Z,17Z)-20-hydroxyicosa-5,8,11,14,17-pentaenoate

(5Z,8Z,11Z,14Z,17Z)-20-hydroxyicosa-5,8,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

11(R)-Hepe(1-)

11(R)-Hepe(1-)

C20H29O3- (317.2117)


An icosanoid anion that is the conjugate base of 11(R)-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5Z,8Z,11Z,14Z,17Z)-19-hydroxyicosa-5,8,11,14,17-pentaenoate

(5Z,8Z,11Z,14Z,17Z)-19-hydroxyicosa-5,8,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

18(S)-Hepe(1-)

18(S)-Hepe(1-)

C20H29O3- (317.2117)


An 18-HEPE(1-) that is the conjugate base of 18(S)-HEPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

15(S)-Hepe(1-)

15(S)-Hepe(1-)

C20H29O3- (317.2117)


A HEPE(1-) that is the conjugate base of 15(S)-HEPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

17(R),18(S)-EETeTr(1-)

17(R),18(S)-EETeTr(1-)

C20H29O3- (317.2117)


A 17,18-EETeTr(1-) in which the epoxy group has (17R,18S)-configuration.

   

8,9-epoxy-(5Z,11Z,14Z,17Z)-eicosatetraenoate

8,9-epoxy-(5Z,11Z,14Z,17Z)-eicosatetraenoate

C20H29O3- (317.2117)


   

(5Z)-7-{(2R,3Z)-3-[(2Z,5Z)-undeca-2,5-dien-1-ylidene]oxiran-2-yl}hept-5-enoate

(5Z)-7-{(2R,3Z)-3-[(2Z,5Z)-undeca-2,5-dien-1-ylidene]oxiran-2-yl}hept-5-enoate

C20H29O3- (317.2117)


   

14,15-Epoxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

14,15-Epoxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

C20H29O3- (317.2117)


   

(5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

(5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C20H29O3- (317.2117)


   

11,12-epoxy-(5Z,8Z,14Z,17Z)-eicosatetraenoate

11,12-epoxy-(5Z,8Z,14Z,17Z)-eicosatetraenoate

C20H29O3- (317.2117)


   

(5Z,7E,11Z,14Z)-9-oxoicosa-5,7,11,14-tetraenoate

(5Z,7E,11Z,14Z)-9-oxoicosa-5,7,11,14-tetraenoate

C20H29O3- (317.2117)


   

(5Z,7E,11Z,14Z,17Z)-9-hydroxyicosa-5,7,11,14,17-pentaenoate

(5Z,7E,11Z,14Z,17Z)-9-hydroxyicosa-5,7,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

(2S)-2,6-bis[(3R)-3-aminobutanamido]hexanoate

(2S)-2,6-bis[(3R)-3-aminobutanamido]hexanoate

C14H29N4O4+ (317.2189)


   

4-Hydroxy-all-trans-13,14-dihydroretinoate

4-Hydroxy-all-trans-13,14-dihydroretinoate

C20H29O3- (317.2117)


   

12(S)-Hepe(1-)

12(S)-Hepe(1-)

C20H29O3- (317.2117)


   

5(S)-Hepe(1-)

5(S)-Hepe(1-)

C20H29O3- (317.2117)


   

butenafine

butenafine

C23H27N (317.2143)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

3-Hydroxynonanoylcarnitine

3-Hydroxynonanoylcarnitine

C16H31NO5 (317.2202)


   

19-HEPE(1-)

19-HEPE(1-)

C20H29O3 (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 19-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoate

(5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoate

(5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

9-HEPE(1-)

9-HEPE(1-)

C20H29O3 (317.2117)


A HEPE(1-) that is the conjugate base of 9-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

8-oxo-ETE(1-)

8-oxo-ETE(1-)

C20H29O3 (317.2117)


An unsaturated fatty acid anion that is the conjugate base of 8-KETE, obtained by deprotonation of the carboxy group.

   

5-HEPE(1-)

5-HEPE(1-)

C20H29O3 (317.2117)


An icosanoid anion that is the conjugate base of 5-HEPE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

18(R)-HEPE(1-)

18(R)-HEPE(1-)

C20H29O3 (317.2117)


An icosanoid anion that is the conjugate base of 18(R)-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

18-HEPE(1-)

18-HEPE(1-)

C20H29O3 (317.2117)


An icosanoid anion that is the conjugate base of 18-HEPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

20-HEPE(1-)

20-HEPE(1-)

C20H29O3 (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 20-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

12-HEPE(1-)

12-HEPE(1-)

C20H29O3 (317.2117)


A HEPE(1-) that is the conjugate base of 12-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoate

(5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,8Z,11Z,17Z)-14,15-Epoxyicosatetraenoate

(5Z,8Z,11Z,17Z)-14,15-Epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,8Z,11Z,17Z)-14,15-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

(1s,10r)-10-heptyl-6-methyl-7,9,12-triazatricyclo[6.3.1.0⁴,¹²]dodeca-4,6,8-triene-5-carboxylic acid

(1s,10r)-10-heptyl-6-methyl-7,9,12-triazatricyclo[6.3.1.0⁴,¹²]dodeca-4,6,8-triene-5-carboxylic acid

C18H27N3O2 (317.2103)